A critical discovery in cancer research is emerging with the use of VHH fragments to re-engage dysfunctional p53. This vital tumor suppressor protein is frequently inactivated in various forms of tumors, leading https://hypebookmarking.com/story21720726/nanobodies-reactivate-the-p53-protein-new-potential-approach-for-cancer-treatment